BR112014014131A2 - formulações de pastilha e cápsula com taxas melhoradas de dissolução de fenofibrato - Google Patents
formulações de pastilha e cápsula com taxas melhoradas de dissolução de fenofibratoInfo
- Publication number
- BR112014014131A2 BR112014014131A2 BR112014014131A BR112014014131A BR112014014131A2 BR 112014014131 A2 BR112014014131 A2 BR 112014014131A2 BR 112014014131 A BR112014014131 A BR 112014014131A BR 112014014131 A BR112014014131 A BR 112014014131A BR 112014014131 A2 BR112014014131 A2 BR 112014014131A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- capsule formulations
- dissolution rates
- improved
- fenofibrate dissolution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
resumo patente de invenção: "formulações de pastilha e cápsula com taxas melhoradas de dissolução de fenofibrato". a presente invenção refere-se ao desenvolver novas formulações de pastilha e de cápsula usando fenofibrato que é difícil de dissolver e controlar a sua taxa de liberação in vitro.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161570381P | 2011-12-14 | 2011-12-14 | |
US61/570,381 | 2011-12-14 | ||
PCT/IB2012/003123 WO2013114153A2 (en) | 2011-12-14 | 2012-12-14 | Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014014131A2 true BR112014014131A2 (pt) | 2017-06-13 |
BR112014014131B1 BR112014014131B1 (pt) | 2021-02-23 |
Family
ID=48790490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014014131-2A BR112014014131B1 (pt) | 2011-12-14 | 2012-12-14 | formulações de pastilha e cápsula com taxas melhoradas de dissolução de fenofibrato e processos para produzir as mesmas |
Country Status (8)
Country | Link |
---|---|
US (2) | US9849184B2 (pt) |
EP (1) | EP2790680B1 (pt) |
JP (3) | JP6149865B2 (pt) |
CN (2) | CN110496108A (pt) |
BR (1) | BR112014014131B1 (pt) |
CA (1) | CA2857430C (pt) |
ES (1) | ES2717470T3 (pt) |
WO (1) | WO2013114153A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7365409B2 (ja) | 2018-06-28 | 2023-10-19 | エイアールエックス エルエルシー | 溶解性単位用量膜構造物を製造するための分配方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785976A (en) * | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US5362496A (en) | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
US6096337A (en) | 1996-06-10 | 2000-08-01 | Spireas; Spiridon | Liquisolid systems and methods of preparing same |
DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
AU7984200A (en) * | 1999-09-21 | 2001-04-24 | Skyepharma Canada Inc. | Surface modified particulate compositions of biologically active substances |
AU8847101A (en) * | 2000-08-31 | 2002-03-13 | Rtp Pharma Inc | Milled particles |
WO2003013607A1 (en) * | 2001-08-07 | 2003-02-20 | Galephar M/F | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR |
DE10207394B4 (de) | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
KR20060085682A (ko) * | 2003-10-10 | 2006-07-27 | 라이프사이클 파마 에이/에스 | 피브레이트 및 스타틴을 함유하는 고형 제제 |
KR20060085686A (ko) * | 2003-10-10 | 2006-07-27 | 라이프사이클 파마 에이/에스 | 피브레이트를 포함하는 고형 제제 |
US20070014846A1 (en) | 2003-10-10 | 2007-01-18 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising fenofibrate and atorvastatin |
US20050096390A1 (en) | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and pravastatin |
EP1861084A1 (en) * | 2005-03-30 | 2007-12-05 | Teva Pharmaceutical Industries Ltd. | Improved formulations of fenofibrate containing menthol or peg/poloxamer |
CN101495150B (zh) * | 2006-08-01 | 2011-06-01 | 大塚制药株式会社 | 药理活性物质的吸收性被改善的药物组合物 |
US8623401B2 (en) * | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
GB2462022B (en) * | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
US8524280B2 (en) | 2008-12-15 | 2013-09-03 | Banner Pharmacaps, Inc. | Methods for enhancing the release and absorption of water insoluble active agents |
-
2012
- 2012-12-14 CA CA2857430A patent/CA2857430C/en active Active
- 2012-12-14 WO PCT/IB2012/003123 patent/WO2013114153A2/en active Application Filing
- 2012-12-14 US US14/364,145 patent/US9849184B2/en active Active
- 2012-12-14 JP JP2014546673A patent/JP6149865B2/ja active Active
- 2012-12-14 BR BR112014014131-2A patent/BR112014014131B1/pt active IP Right Grant
- 2012-12-14 CN CN201910680594.8A patent/CN110496108A/zh active Pending
- 2012-12-14 ES ES12865541T patent/ES2717470T3/es active Active
- 2012-12-14 EP EP12865541.2A patent/EP2790680B1/en active Active
- 2012-12-14 CN CN201280061529.3A patent/CN103987383A/zh active Pending
-
2017
- 2017-02-16 JP JP2017026536A patent/JP6391730B2/ja active Active
- 2017-02-16 JP JP2017026537A patent/JP6391731B2/ja active Active
- 2017-11-21 US US15/819,847 patent/US11497811B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2857430A1 (en) | 2013-08-08 |
JP2017122099A (ja) | 2017-07-13 |
JP6391731B2 (ja) | 2018-09-19 |
US20140377342A1 (en) | 2014-12-25 |
CN103987383A (zh) | 2014-08-13 |
EP2790680B1 (en) | 2018-12-12 |
CA2857430C (en) | 2019-12-03 |
BR112014014131B1 (pt) | 2021-02-23 |
JP2015500330A (ja) | 2015-01-05 |
EP2790680A2 (en) | 2014-10-22 |
US9849184B2 (en) | 2017-12-26 |
US11497811B2 (en) | 2022-11-15 |
US20180092979A1 (en) | 2018-04-05 |
WO2013114153A2 (en) | 2013-08-08 |
CN110496108A (zh) | 2019-11-26 |
JP2017114885A (ja) | 2017-06-29 |
JP6149865B2 (ja) | 2017-06-21 |
WO2013114153A3 (en) | 2013-10-31 |
JP6391730B2 (ja) | 2018-09-19 |
ES2717470T3 (es) | 2019-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022011225A (es) | Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif. | |
TWD160104S (zh) | 展示架之部分 | |
TWD163948S (zh) | 顯示面板的圖形化使用者介面之部分 | |
TWD164760S (zh) | 可攜式顯示裝置 | |
FR2994364B3 (fr) | Dispositif d'affichage affichant une pluralite de vues de contenu, dispositif de lunettes se synchronisant avec l'une des vues de contenu, et procedes connexes | |
IN2014DN10260A (pt) | ||
TWD158984S (zh) | 座標輸入器 | |
TWD158983S (zh) | 座標輸入器之部分 | |
BR112014001543A2 (pt) | preparação de liberação sustentada de ivabradina ou seus sais farmaceuticamente aceitáveis | |
IN2015DN03921A (pt) | ||
TN2012000507A1 (en) | Enteric tablet | |
TR201010683A1 (tr) | Vildagliptin formülasyonları. | |
PE20151543A1 (es) | Composicion farmaceutica oral de sales sulfato para comprimidos de uso dual y metodos para su uso | |
MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
BR112014014131A2 (pt) | formulações de pastilha e cápsula com taxas melhoradas de dissolução de fenofibrato | |
IN2015DN03929A (pt) | ||
BR112014000836A2 (pt) | páginas definidas por usuário para aeronave | |
TWD164910S (zh) | 織物 | |
JP2012226552A5 (pt) | ||
MX2015008757A (es) | Formulaciones de lorazepam de liberacion controlada. | |
FR2985172B1 (fr) | Prothese d'epaule sur fracture avec mecanisme d'assemblage retentif et universel | |
BR112015020773A2 (pt) | composição farmacêutica de liberação temporizada | |
BR112015006642A2 (pt) | metadoxina, composição farmacêutica e composição farmacêutica de liberação prolongada | |
CN302568472S (zh) | 鼓形表 | |
QIU et al. | Study on the Infrastructure for Spatial Information in Germany |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/12/2012, OBSERVADAS AS CONDICOES LEGAIS. |